CA Patent

CA2217902A1 — Use of gammahydroxybutyrric acid for the treatment of demential syndromes

Assigned to Laboratorio Farmaceutico CT SRL · Expires 1999-01-07 · 27y expired

What this patent protects

Use of gammahydroxybutyrric acid for the preparation of pharmaceutical compositions for the treatment of demential syndromes.

USPTO Abstract

Use of gammahydroxybutyrric acid for the preparation of pharmaceutical compositions for the treatment of demential syndromes.

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

Patent Metadata

Patent number: CA2217902A1
Jurisdiction: CA
Classification: —
Expires: 1999-01-07
Drug substance claim: No
Drug product claim: No
Assignee: Laboratorio Farmaceutico CT SRL
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.